Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,986 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pancreatic body adenocarcinoma with neuroendocrine tumor characteristics: A case report.
Tajima H, Kitagawa H, Shoji M, Watanabe T, Nakanuma S, Okamoto K, Sakai S, Kinoshita J, Makino I, Furukawa H, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Itoh H, Takamura H, Ninomiya I, Fushida S, Fujimura T, Ohta T, Satoh H, Ikeda H, Harada K, Nakanuma Y. Tajima H, et al. Among authors: furukawa h. Oncol Lett. 2014 Apr;7(4):1049-1052. doi: 10.3892/ol.2014.1873. Epub 2014 Feb 12. Oncol Lett. 2014. PMID: 24944667 Free PMC article.
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.
Tajima H, Ohta T, Kitagawa H, Okamoto K, Sakai S, Kinoshita J, Makino I, Furukawa H, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Kitamura S, Ikeda H, Tsuneyama K. Tajima H, et al. Among authors: furukawa h. Oncol Lett. 2012 Jun;3(6):1186-1190. doi: 10.3892/ol.2012.657. Epub 2012 Mar 26. Oncol Lett. 2012. PMID: 22783415 Free PMC article.
Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report.
Tajima H, Ohta T, Shinbashi H, Hirose A, Tsukada T, Okamoto K, Nakanuma S, Sakai S, Furukawa H, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Mouri H, Ohtsubo K. Tajima H, et al. Among authors: furukawa h. Oncol Lett. 2012 Dec;4(6):1281-1284. doi: 10.3892/ol.2012.909. Epub 2012 Sep 12. Oncol Lett. 2012. PMID: 23226802 Free PMC article.
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line.
Hirose A, Tajima H, Ohta T, Tsukada T, Okamoto K, Nakanuma S, Sakai S, Kinoshita J, Makino I, Furukawa H, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Harada S. Hirose A, et al. Among authors: furukawa h. Oncol Lett. 2013 Oct;6(4):915-920. doi: 10.3892/ol.2013.1494. Epub 2013 Jul 25. Oncol Lett. 2013. PMID: 24137436 Free PMC article.
[A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker].
Terakawa H, Oyama K, Watanabe T, Tsukada T, Okamoto K, Kinoshita J, Furukawa H, Makino I, Nakamura K, Hayashi H, Inokuchi M, Nakagawara H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Ohta T. Terakawa H, et al. Among authors: furukawa h. Gan To Kagaku Ryoho. 2014 Apr;41(4):491-3. Gan To Kagaku Ryoho. 2014. PMID: 24743367 Japanese.
Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Shoji M, Okamoto K, Nakanuma S, Sakai S, Makino I, Furukawa H, Hayashi H, Nakamura K, Inokuchi M, Nakagawara H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fujimura T, Masakazu Y, Hirakawa K, Ohta T. Kinoshita J, et al. Among authors: furukawa h. Oncol Rep. 2014 Jul;32(1):89-96. doi: 10.3892/or.2014.3210. Epub 2014 May 23. Oncol Rep. 2014. PMID: 24859429
Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer.
Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Itoh H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Wakayama T, Iseki S, Shimizu K. Yoshimoto K, et al. Among authors: furukawa h. Oncol Rep. 2012 Sep;28(3):791-6. doi: 10.3892/or.2012.1896. Epub 2012 Jul 3. Oncol Rep. 2012. PMID: 22766603 Free PMC article.
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer.
Tajima H, Kitagawa H, Tsukada T, Nakanuma S, Okamoto K, Sakai S, Makino I, Furukawa H, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Fujita H, Itoh H, Takamura H, Ninomiya I, Fushida S, Fujimura T, Ohta T. Tajima H, et al. Among authors: furukawa h. Mol Clin Oncol. 2013 Jul;1(4):768-772. doi: 10.3892/mco.2013.133. Epub 2013 May 27. Mol Clin Oncol. 2013. PMID: 24649244 Free PMC article.
Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer.
Tajima H, Kitagawa H, Tsukada T, Okamoto K, Nakanuma SI, Sakai S, Makino I, Furukawa H, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Itoh H, Fujita H, Takamura H, Ninomiya I, Fushida S, Fujimura T, Ohta T, Koda W, Minami T, Ryu Y, Sanada J, Gabata T, Matsui O, Sai Y. Tajima H, et al. Among authors: furukawa h. Mol Clin Oncol. 2013 Sep;1(5):869-874. doi: 10.3892/mco.2013.152. Epub 2013 Jul 23. Mol Clin Oncol. 2013. PMID: 24649263 Free PMC article.
1,986 results